This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
News: Publications

Commentary: Homozygous familial hypercholesterolaemia: new hope for getting patients to goal?

Friday 24 April 2020   (1 Comments)
Share |

Management of homozygous familial hypercholesterolaemia is challenging. What are the prospects for attaining LDL cholesterol goal with novel therapies? This latest commentary discusses the new findings for evinacumab, an ANGPTL3 monoclonal antibody.

Read the commentary >>


Mutaz R. Alkhnifsawi says...
Posted Sunday 26 April 2020
Informative . In Iraq , PCSK9 inhibitors are not available and government can not support patients who are in need for such drugs . Three of our HoFH patients who use these drugs did not benefit from them and LDL-c did not fall , it even showed paradoxical rise with continued therapy unfortunately !

Membership Software Powered by YourMembership  ::  Legal